Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias.
Claudia CicognolaOskar HanssonPhilip ScheltensHlin KvartsbergHenrik ZetterbergCharlotte E TeunissenKaj BlennowPublished in: Alzheimer's research & therapy (2021)
N-224 tau can distinguish AD subjects from SCD and can discriminate subgroups of non-AD dementias from AD. Therefore, N-224 may be a useful addition to the tau biomarker toolbox for the study of tau species in CSF and for better understanding disease pathogenesis.